Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 3
2008 1
2009 3
2010 2
2011 1
2012 1
2013 3
2014 1
2016 6
2017 3
2018 3
2019 4
2020 3
2021 5
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
IMI 2023 Digest.
Sankaridurg P, Berntsen DA, Bullimore MA, Cho P, Flitcroft I, Gawne TJ, Gifford KL, Jong M, Kang P, Ostrin LA, Santodomingo-Rubido J, Wildsoet C, Wolffsohn JS. Sankaridurg P, et al. Among authors: berntsen da. Invest Ophthalmol Vis Sci. 2023 May 1;64(6):7. doi: 10.1167/iovs.64.6.7. Invest Ophthalmol Vis Sci. 2023. PMID: 37126356 Free PMC article.
Authors' Response.
Gregory HR, Nti AN, Wolffsohn JS, Berntsen DA, Ritchey ER. Gregory HR, et al. Among authors: berntsen da. Optom Vis Sci. 2021 Aug 1;98(8):997-998. doi: 10.1097/OPX.0000000000001760. Optom Vis Sci. 2021. PMID: 34393207 Free PMC article. No abstract available.
Delaying the Onset of Nearsightedness.
Berntsen DA, Walline JJ. Berntsen DA, et al. JAMA. 2023 Feb 14;329(6):465-466. doi: 10.1001/jama.2022.24386. JAMA. 2023. PMID: 36786802 No abstract available.
Atropine, 0.01%, for Myopia Control.
Walline JJ, Berntsen DA. Walline JJ, et al. Among authors: berntsen da. JAMA Ophthalmol. 2023 Aug 1;141(8):766-767. doi: 10.1001/jamaophthalmol.2023.3076. JAMA Ophthalmol. 2023. PMID: 37440252 No abstract available.
IMI 2021 Yearly Digest.
Jong M, Jonas JB, Wolffsohn JS, Berntsen DA, Cho P, Clarkson-Townsend D, Flitcroft DI, Gifford KL, Haarman AEG, Pardue MT, Richdale K, Sankaridurg P, Tedja MS, Wildsoet CF, Bailey-Wilson JE, Guggenheim JA, Hammond CJ, Kaprio J, MacGregor S, Mackey DA, Musolf AM, Klaver CCW, Verhoeven VJM, Vitart V, Smith EL 3rd. Jong M, et al. Among authors: berntsen da. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):7. doi: 10.1167/iovs.62.5.7. Invest Ophthalmol Vis Sci. 2021. PMID: 33909031 Free PMC article. Review.
Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial.
Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, Bickle KM, Schulle KL, Nixon A, Pierce GE, Berntsen DA; BLINK Study Group. Walline JJ, et al. Among authors: berntsen da. JAMA. 2020 Aug 11;324(6):571-580. doi: 10.1001/jama.2020.10834. JAMA. 2020. PMID: 32780139 Free PMC article. Clinical Trial.
IMI - Clinical Myopia Control Trials and Instrumentation Report.
Wolffsohn JS, Kollbaum PS, Berntsen DA, Atchison DA, Benavente A, Bradley A, Buckhurst H, Collins M, Fujikado T, Hiraoka T, Hirota M, Jones D, Logan NS, Lundström L, Torii H, Read SA, Naidoo K. Wolffsohn JS, et al. Among authors: berntsen da. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M132-M160. doi: 10.1167/iovs.18-25955. Invest Ophthalmol Vis Sci. 2019. PMID: 30817830 Review.
54 results